MedKoo Cat#: 598959 | Name: Bismuth camphocarbonate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Bismuth camphocarbonate is used as a treatment for herpes zoster.

Chemical Structure

Bismuth camphocarbonate
Bismuth camphocarbonate
CAS#19495-28-4

Theoretical Analysis

MedKoo Cat#: 598959

Name: Bismuth camphocarbonate

CAS#: 19495-28-4

Chemical Formula: C33H45BiO9

Exact Mass:

Molecular Weight: 794.69

Elemental Analysis: C, 49.88; H, 5.71; Bi, 26.30; O, 18.12

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Bismuth camphocarbonate; Bi-Valeas; Cardyl; Solmuth; Rectobismutina; Angimuth;
IUPAC/Chemical Name
bismuth(III) 4,7,7-trimethyl-3-oxobicyclo[2.2.1]heptane-2-carboxylate
InChi Key
UKRHKPCWTGYGIN-UHFFFAOYSA-K
InChi Code
InChI=1S/3C11H16O3.Bi/c3*1-10(2)6-4-5-11(10,3)8(12)7(6)9(13)14;/h3*6-7H,4-5H2,1-3H3,(H,13,14);/q;;;+3/p-3
SMILES Code
CC1(C)C2(C)CCC1C(C([O-])=O)C2=O.CC3(C)C4(C)CCC3C(C([O-])=O)C4=O.CC5(C)C6(C)CCC5C(C([O-])=O)C6=O.[Bi+3]
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 794.69 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: LAMARINA A, MUSCHIO R. [Spectrophotometric research on bismuth in carcinoma and in round ulcers of the stomach in patients treated with bismuth-lecithin camphocarbonate]. Arch Sci Med (Torino). 1962 Mar;113:196-205. Italian. PubMed PMID: 14461706. 2: LOT G. [Bismuth camphocarbonate in the treatment of herpes zoster]. Arch Ital Dermatol Sifilogr Venereol. 1950;23(4):300-4. Undetermined Language. PubMed PMID: 14772021. 3: BRAVO-PACHECO. [Treatment of acture tonsillitis by rectal administration of bismuth camphocarbonate]. Rev Laryngol Otol Rhinol (Bord). 1951 Mar-Apr;72(3-4):138-48. Undetermined Language. PubMed PMID: 14845207. 4: MAGGIORELLI E. [Spontaneous decomposition and preservation of bismuth camphocarbonate]. Boll Chim Farm. 1960 Apr;99:212-4. Italian. PubMed PMID: 14419841. 5: MOUSSET G. [Camphorcarbonate of bismuth; treatment of lymphoid congestion]. Concours Med. 1951 Feb 5;74(5):395. Undetermined Language. PubMed PMID: 14905852.